دورية أكاديمية
Update on therapy of relapsed and refractory multiple myeloma
العنوان: | Update on therapy of relapsed and refractory multiple myeloma |
---|---|
المؤلفون: | Vekemans, M-C., Beel, K., CAERS, Jo, Meuleman, N., Bries, G., Demuynck, H., DE PRIJCK, Bernard, De Samblanx, H., Deweweirea, A., Fostier, K., Mineur, P., Vaes, M., Vande Broeck, I., Vande Velde, A., Van Droogenbroeck, J., Vlummers, P., Wu, K-L., Schots, R., Delforge, M., Doyen, C. |
المصدر: | Belgian Journal of Hematology, 8, 53-65 (2017) |
بيانات النشر: | Ariez Medical Publishing |
سنة النشر: | 2017 |
المجموعة: | University of Liège: ORBi (Open Repository and Bibliography) |
مصطلحات موضوعية: | novel drugs, relapsed and refractory myeloma, salvage chemotherapy, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie |
الوصف: | peer reviewed ; The prognosis for multiple myeloma patients has improved substantially over the past decade with the development of more effective chemotherapeutic agents and regimens that possess a high level of anti-tumour activity. However, nearly all multiple myeloma patients ultimately relapse, even those who experience a complete response to initial therapy. Management of relapsed disease remains a critical aspect of multiple myeloma care and an important area of ongoing research. This manuscript from the Belgian Haematology Society multiple myeloma subgroup provides some recommendations on the management of relapsed disease. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 2033-3749 |
العلاقة: | urn:issn:2033-3749; https://orbi.uliege.be/handle/2268/225860Test; info:hdl:2268/225860; https://orbi.uliege.be/bitstream/2268/225860/1/bjh_2017_8-2-53-65.pdfTest |
الإتاحة: | https://orbi.uliege.be/handle/2268/225860Test https://orbi.uliege.be/bitstream/2268/225860/1/bjh_2017_8-2-53-65.pdfTest |
حقوق: | open access ; http://purl.org/coar/access_right/c_abf2Test ; info:eu-repo/semantics/openAccess |
رقم الانضمام: | edsbas.F81222E0 |
قاعدة البيانات: | BASE |
تدمد: | 20333749 |
---|